Jolypharma SA
The score of Jolypharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +41 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Jolypharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 93,466 € | ||||
| Equity | 952,385 € | ||||
| Cash | 235,737 € | ||||
| EBITDA | 165,125 € | ||||
| Total assets | €1.20m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 11 Sep 2024
- Year ended 31 Dec 2022filed on 18 Sep 2023
- Year ended 31 Dec 2021filed on 16 Oct 2022
Jolypharma's financial analysis
- Solvency79.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Jolypharma
Jolypharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.899.537
- VAT number
- BE0473899537
- Peppol
- Registered · 0208:0473899537 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 24 Jan 2001
- Registered office
- 3770 Riemst
- Latest accounts
- 2025 · filed on 12 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Jolypharma (SA) has been based in Riemst since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 93,466 € and equity of 952,385 €; its revenue is not published. Its solvency stands at 79.3%, above the median of its sector (44.2%).
Companies similar to Jolypharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Dewaele-Witdouck Retail sale of pharmaceutical products Frasnes-lez-Anvaing · balance sheet €1.20m
- Hingiphar Retail sale of pharmaceutical products Kampenhout · balance sheet €1.20m
- Apotheek Dassen Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €1.20m
- Hulspharma Retail sale of pharmaceutical products Hulshout · balance sheet €1.20m
- Diximo Retail sale of pharmaceutical products Ferrières · balance sheet €1.20m
- Dalemans Retail sale of pharmaceutical products Buggenhout · balance sheet €1.20m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Aa.Pharma Turnhout Retail sale of pharmaceutical products Turnhout · balance sheet €1.21m
Frequently asked questions about Jolypharma
What is the revenue of Jolypharma?
Jolypharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Jolypharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0473899537 for Jolypharma, if the company is VAT-registered. Its company number (CBE) is 0473.899.537.
Where is the registered office of Jolypharma?
According to the CBE register, the registered office of Jolypharma is in 3770 Riemst.
What is the equity of Jolypharma?
At the close of the 2025 financial year, the equity of Jolypharma amounts to 952,385 €, a solvency of 79.3% of total assets.
Who manages Jolypharma?
The register lists 1 active mandates at Jolypharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Jolypharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →